Annunziato, Francesco
Azienda Ospedaliero-Universitaria Careggi
9 papers on CoChatORCID 0000-0001-8798-7589
Most cited papers
- Verified
Phenotypic and functional features of human Th17 cells
Annunziato, F., Cosmi, L., Santarlasci, V., Maggi, L., Liotta, F., Mazzinghi, B., Parente, E., Filì, L., Ferri, S., Frosali, F., et al. (2007) · The Journal of Experimental Medicine
Psoriasis: Treatment and PathogenesisT-cell and B-cell Immunology
Cited by 1,861
- Verified
The 3 major types of innate and adaptive cell-mediated effector immunity
Annunziato, F., Romagnani, C., & Romagnani, S. (2015) · Journal of Allergy and Clinical Immunology
IL-33, ST2, and ILC PathwaysT-cell and B-cell Immunology
Cited by 818
- Verified
Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition)
Cossarizza, A., Chang, H., Radbruch, A., Abrignani, S., Addo, R., Akdis, M., Andrä, I., Andreata, F., Annunziato, F., Arranz, E., et al. (2021) · European Journal of Immunology
T-cell and B-cell ImmunologyMonoclonal and Polyclonal Antibodies Research
Cited by 531
- Verified
Impaired immune cell cytotoxicity in severe COVID-19 is IL-6 dependent
Mazzoni, A., Salvati, L., Maggi, L., Capone, M., Vanni, A., Spinicci, M., Mencarini, J., Caporale, R., Peruzzi, B., Antonelli, A., et al. (2020) · Journal of Clinical Investigation
COVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 Research
Cited by 502
- Verified
CD161 is a marker of all human IL‐17‐producing T‐cell subsets and is induced by RORC
Maggi, L., Santarlasci, V., Capone, M., Peired, A., Frosali, F., Crome, S. Q., Querci, V., Fambrini, M., Liotta, F., Levings, M. K., et al. (2010) · European Journal of Immunology
Psoriasis: Treatment and PathogenesisT-cell and B-cell Immunology
Cited by 362
- Verified
Type 17 T helper cells-origins, features and possible roles in rheumatic disease.
Annunziato, F., Cosmi, L., Liotta, F., Maggi, E., & Romagnani, S. (2009) · Nature Reviews Rheumatology
Psoriasis: Treatment and PathogenesisT-cell and B-cell Immunology
Cited by 212
- Verified
Heterogeneity of human effector CD4+ T cells
Annunziato, F., & Romagnani, S. (2009) · Arthritis Research & Therapy
Psoriasis: Treatment and PathogenesisT-cell and B-cell Immunology
Cited by 194
- Verified
First-dose mRNA vaccination is sufficient to reactivate immunological memory to SARS-CoV-2 in subjects who have recovered from COVID-19
Mazzoni, A., Di Lauria, N., Maggi, L., Salvati, L., Vanni, A., Capone, M., Lamacchia, G., Mantengoli, E., Spinicci, M., Zammarchi, L., et al. (2021) · Journal of Clinical Investigation
SARS-CoV-2 and COVID-19 ResearchImmune responses and vaccinations
Cited by 139
- Verified
Disease correlates and clinical relevance of hereditary α-tryptasemia in patients with systemic mastocytosis
Sordi, B., Vanderwert, F., Crupi, F., Gesullo, F., Zanotti, R., Bonadonna, P., Crosera, L., Elena, C., Fiorelli, N., Ferrari, J., et al. (2023) · Journal of Allergy and Clinical Immunology
Mast cells and histamineGastrointestinal Tumor Research and Treatment
Cited by 51
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free